Page 191 - product-manual
P. 191

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





                               Riboflavin [Vitamin B ] (C H N O )
                                                         2    17  20  4  6
                               The major function of riboflavin is to serve as a precursor of the coenzymes flavin mononucleotide
                               (FMN) and flavin adenine dinucleotide (FAD). Synthesis of the coenzymes from riboflavin is
                               under the control of thyroid hormones. A deficiency of riboflavin impacts other vitamins because
                               flavin coenzymes are involved in their metabolism. These vitamins include folic acid, pyridoxine,
                               niacin, and vitamins K and D. Acute riboflavin deficiency in dogs and cats results in anorexia, body
                               weight loss, decreased activity, hypothermia, decreased respiratory rate, progressive weakness,
                               ataxia, sudden collapse to semicomatose state, and death. Chronic riboflavin deficiency has been
                               associated with anorexia, body weight loss, muscular weakness, flaking dermatitis of the abdomen
                               and medial surface of the hind legs, and ocular lesions (NRC, 2006).




            TOXICOLOGY  Toxicity for vitamin B  has not been documented in dogs and cats when administered orally in therapeutic

                                   2
                 doses. Oral LD  of vitamin B  is >10 g/kg of body weight in rats (NRC, 1987).
                                          2
                             50





                   DRUG    Validated  interactions  studies  do  not  exist  for  riboflavin  preparations.  However,  anticholinergic
          INTERACTIONS     drugs and probenecid may decrease riboflavin absorption. Riboflavin can affect the absorption of
                           tetracycline.  Tricyclic  antidepressants,  phenothiazines,  doxorubicin,  and  phenytoin  may  reduce
                           levels  of  riboflavin  in  the  body.  Methotrexate  can  inhibit  the  utilization  of  riboflavin  (UMMC,
                           2012c).





































        6  |   VimForte -VM TM
   186   187   188   189   190   191   192   193   194   195   196